Systemic treatments for metastatic or unresectable renal cell carcinoma (mRCC) are rapidly evolving. This study aimed at investigating challenges in the care of mRCC to inform future educational interventions for health care providers (HCPs).
The sequential mixed-method design consisted of a qualitative phase (semistructured interviews) followed by a quantitative phase (online surveys). Participants included US-based medical oncologists, nephrologists, physician assistants, nurse practitioners, and registered nurses. Interview transcripts were thematically analyzed. Survey data was descriptively and inferentially analyzed.
Forty interviews and 265 surveys were completed. Analysis revealed four challenges in the care of mRCC patients. A challenge in staying current with emerging evidence and treatment recommendations was found with 33% of surveyed HCPs reporting suboptimal skills interpreting published evidence on the efficacy and safety of emerging agents. A challenge weighing patient health and preferences in treatment decisions was found, especially among HCPs with 3 to 10 years of practice (37%) who reported suboptimal skills in assessing patients' tolerance to side effects. Promoting a collaborative care approach to the management of immune-related adverse events was a challenge, specifically related to barriers involving nephrologists (eg, diverging treatment goals). Breakdowns in communication were reported (46% of HCPs), especially in the monitoring of side effects and treatment adherence.
This study revealed key challenges faced by HCPs when treating and managing patients with mRCC across multiple providers. Future interventions (eg, community of practice) should aim to address the identified gaps and promote a team-based approach to care that strengthens the complementary competencies of HCPs involved.
Clinical genitourinary cancer. 2023 Mar 18 [Epub ahead of print]
Patrice Lazure, Matthew T Campbell, Monica Augustyniak, Edgar A Jaimes, Mehmet A Bilen, Emily A Lemke, Eric P Cohen, Ginny Jacobs
AXDEV Group Inc., Brossard, QC, Canada. Electronic address: ., The University of Texas MD Anderson Cancer Center, Houston, TX., AXDEV Group Inc., Brossard, QC, Canada., Memorial Sloan Kettering Cancer Center, New York, NY., Winship Cancer Institute of Emory University, Atlanta, GA., Medical College of Wisconsin, Wauwatosa, WI., New York University School of Medicine, New York, NY., AXDEV Global Inc., Virginia Beach, VA.